pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-2116 |
Genomic Coordinates | chr15: 59171183 - 59171262 |
Description | Homo sapiens miR-2116 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-2116-3p | |||||||||||||||||||||
Sequence | 51| CCUCCCAUGCCAAGAACUCCC |71 | |||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||
Experiments | 454 | |||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | LMLN | ||||||||||||||||||||
Synonyms | GP63, INV, IX14, MSP | ||||||||||||||||||||
Description | leishmanolysin like peptidase | ||||||||||||||||||||
Transcript | NM_001136049 | ||||||||||||||||||||
Other Transcripts | NM_033029 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on LMLN | |||||||||||||||||||||
3'UTR of LMLN (miRNA target sites are highlighted) |
>LMLN|NM_001136049|3'UTR 1 GAATGGAAAAGTGGATCTTCAAGATATTCTTTTATGTTATGTTCTTGTGAACAAAGCACAAAGTTTGAGTGAGTGCCAAC 81 CTATGCAGATGGTAGAAGTGGCATTCCTGGCTTTGGCTTGGAAGAATTGACGACCATCAGACCTTGAAGCAGAACTTCAC 161 AGCAGCCTGTCCTCATCAGCAACCCAACCACCTTCATCAGCAACCCAACCACCTTCATCAGCAACCCAACCACCTCGTCA 241 GCAACCCAACCACCTCGTCAGCAACCCAACCACCTCGTCAGCAACCCAGCCACCTTCATCAGCAACCCAACCACCTCATC 321 AGCAACCCAGCCACCTTCATCAGCAACCCAACCACCTCATCAGCAAACCAACCACTTTCATCTGCAACCCAACCACTTTC 401 ATCAGCAACTCAACACCTTCATCTGCAACCCAACCACCTTCATCAGCAAACCAACCACCTTCTTCAGCAACCCAACCACC 481 TCATCTTGGAGAAGGAGAAGGAACTGCAAGCCACCAAGTCTTCATTTTTCAGGGTTTGTAATCTTCCCAAAGTTTTCCTT 561 TGAAAATAGGATAATGGGTGGAATTTTCAGAGTGATTACATACCTCAACATTTTTATTAACATACAACAATGGGAAAGTT 641 CATCATCCATATACTGCAGTCACTTAAACAACAGCCAATTATTGCAAGATTAGAATTGGAGATCTTGTCCTCAAAAGTAT 721 AAATTGTCCTTTGAGTTATAGAAAATAATGGAATTGGGATTTCTACATATCATTATTATACCTATTTTAAATTTAATGGC 801 AGCCAGGCATGGTTCCAGCTACTTGGGAGGCTGAGGCAGGAGGATCGCTTGAGCCCAGGAGTTCAAGGCTGCAGTGAGCT 881 ATGATTGCACCACTGTATTCCAGCCTGCACGATAGAGTTAGACCCTGTATCTTAAAAAAAAAAAAATTAATGGCTGGTAT 961 ATAGTAAACTTAATTCACTGTTCCCATTGTTCTAAAGAATTTTTTTAAATAATGTTTCATTAAATCTTATGATTTAACCG 1041 TGCTTGCCCTTTTTGCCAGCTATGTGGCAGTTTACGGCAGAACTGCTGTCAGTGTGCTGGTAGCCCTCTATTCATCCCTC 1121 CTCAGAGCCCAGCTTCCAGAACTGCTATCACTGTGCTGGTAGCCCTCTGTATTCATCCCTCTTCAGAGCTCAGCTTCTGG 1201 TTGTATTCTCCATGAGTTTAATAATGACATGAAAAAATGTGGAAGCCGAGAGAGTAAAATACTCTGCCCTGTAAAAACAT 1281 GGAAGACATGCAAACAGAAAAAAAATAATTGTATTGTTTTAGATAATACTTAAGACAACTGTGAAACAACAAAAACACAA 1361 CTATTCCTTTGTGACCGATGAAGATAAAAAGAAATTCTGGTAAAGACGGGTATGCAGTTTTTTAAAATGGGTTAAGAAAT 1441 TGTTGCAGAAGAATTTCTAACATCTGAAAATGGTTTTATGTTTAAGAAGGATGGTCTGAATTGTGTACTAATAGCAAGGT 1521 ATAAGTTTGGTGTAGAGCCTATCCAGTAGCGTCCACTGTACCACTTTTAAGTAAGACTCAGTCCACAGAAGCTGGAAGAT 1601 TGCCTTCGCTTTAAATATCCTTTACCTTCTGCATTTGACACTCCTCCTGTTACTACATAGATTCCGGTCCCCAGAAGCAA 1681 TTTTACACTGGTACTAGAGCTTACCAGCCCCATTTAGTAATTTTTAATGGCTAGATGAGGTTTAACAAGAATATGAAAAG 1761 AAAAAAGAAAAAATATATTCATGAATGATAGGCGATGCCCATTCTTTCTCTCAAGCTAATGAAGTCCTATGGCATTCTAA 1841 CCACAACCCTCGGACAGACTCCTCCTATTCCTCCATGGCATTGTAACCACAACCCTCGGACAGACTCCTCCTATTCCTCC 1921 ATGGCATTGTAACCACAACCCTCGGACAGACTCCTCCTACTCCTCCATGGCATTGTAACCACAACCCTCGGACAGACTCC 2001 TCCTACTCCTCCATGGCATTGTAACCACAACCCTCGGACAGACTCCTCCTACTCCTCCATGGCATTGTAACCACAACCCT 2081 CGGACAGACTCCTCCTATTCCTCCATGGCATTGTAACCACAACCCTCGGACAGACTCCTCCTATTCCTCCATGGCATTGT 2161 AACCACAACCCTCGGACAGACTCCTCCTATTCCTCCATGGCATTGTAACCACAACCCTCGGACAGACTCCTATTCCTCCA 2241 TGGCATTGTAACCACAACCCTCGGACAGACTCCTCCTATTCCTCCATGGCATTGTAACCACAACCCTCGGACAGACTCCT 2321 TCTGTTCCTCCTTTCCTCGTCCTTCCCTGCTTTTCGTCCATTCAGCATATAGCTATTCAGTACTCCATTGAAGAAATTAT 2401 GCTAAGTGAGCAAAGCAACATAATTACTAAGAATTAATTCTGATTATTTGGCACTAGAGCCAACAGCAACCCCAGCACAG 2481 AGGAAAGTCGCTTTTTTTTCAAATGCATAAATTTAAAGTATGTATTTGCATGCAGTTTTAAATGGGAGGTATTTGTCATT 2561 GTGAAAAGCTGGGAATCTCAAACATAGTCAACTTAACTAAAAAGAAGCTAATACAGGTTGAGCATTCCTAATCCAAAAAT 2641 CCAGAATCCAAATTGCTCCAAAATCTGAAACTTTCTGAATGCTGACCTGATACTACAAGTAGAAAATTCCACATACAAGT 2721 ACTTAACACAAACTTTGTTTCATGCACAAACTACTAAAAATATTGTATAAAATTACCTTCAGGCAGTGTGTGTAGTTATA 2801 TATGAAACATGAATTTCATGTTTAGACTTGGGTCCATGCCCAAGATACCTCATTAGGTATCTGTAAATATCCGAAATCCA 2881 AAAAAAAGTCTGAAATCTGAAACACTTCTGGTCCCAAGCATTTCAGTAAGTGATGCTCAACCTGCGTAATGGTCTGCGGG 2961 CCAGTGCTCATTTTCTGCCTATGTTGTACATACTTTAAATTGTGTAAATTAAAAGTCAAAGCAAAGAGTCTATTTTTAAA 3041 GAAACTTACAATAATCTAAACATATACTTCTTATGATTATGAATCATCCTGCAAAGCTGAATGAAGAATTTTACCAAAAA 3121 TACAATGAATTAATCATATATTTGAGAGTCACAGTGATAGGTTCGACTATATTTTGACTGTTGTGTAGTGGCACCGTTTA 3201 GGTAGTATTGTTTCTGAGCATGGTGCTTTTTATACTTGAAATATATTTTTGCTTTATTTTTTATTGATATAATTATATTT 3281 GCACTAATGGCTTTCTGAAGAAAATATTATAGATGACATTTTTTGTATATATATTTATTAAGCTTGGGAACCTGGTCGCC 3361 CAGTGTTTTCTCTGGACAAATGTGAAACTGGATAAAGTATGGATAAAGTCTTGAGTTCCTCAGGGTAACTGTGTTGATGT 3441 CTCCCGTCCTCTTCAGTAAGGCTTGAATATGATTTTACTCATCATTGATTCTGCATAGTGTACCCAGCAAGACTTAGAAG 3521 GACACTGAACCTGTCAGAGATTTTAAGAGGCACATTTTAGTCACTTTGAATATGGTAGTGGTGGGCGCGGTGACTGAAGC 3601 CTGTAATCTCAGCACTTCGGGAGGCCAAGGCAAGCAGATCACGAGATCAGGAGTTTGAGGTTACAGTGAGCTGATCGCAC 3681 CACTGCACTGCAGCCTGGATGACAGAGTGAGACTTTCTTGGGAAAAAAAAAAATGACAGTGAAGCAGACTTTTAGAATCC 3761 GAGATGTCATTGCAGAATTATTGGTATAAAATTCAGCTGCAAAGTGAAGAAATTGAAATGGCCCACACGTTGATATCCTG 3841 TGGCAGGTTATACCCTTCATGTTAGCAAAGACGAAGCCACGTCGCTGTGTTAAGAGGGACAGGCTGGGCCGGCTGCAGCT 3921 GTAGTGGAAGTGAGGGACACAGGGAAGGAATGGGGAGCAGCAATTTGGGGACAGTAGACTGGAGTCACTTTCTGACTCAA 4001 AAAGGGTCAAGTACTTATTAAAAACTATCTTGGTTTTCTGTTCAGACTTAGGCTCATTTTGATCATTTTAAGGTCCCAGT 4081 TGTCAAAAATATCAAGTGAATTTGTCTCAGGTTTTCAGAAACAAAATTTACAGGAAGGAAGCAAAAGCCATGTCAGTAGC 4161 CTTGAGCTGACAGCTTTAAAGAAACTGGCAAACAGGTAGGTTGTCCTCATATAGATCCTTCCAGTATTCTGAAAAACATC 4241 CTTTTATTTCTTAAAACCAGTAACCCTTACATTTTTCCTATAGGATAGTTATTTTTGTTGAGATCAAATAGACATTCTAT 4321 AAATGTTATAAATTATGCTTGCAGTTACTCAGCCTATCTAGGCTTAAGGTTTATCAATATTTGAAGTTGAAACATCATCT 4401 TATGAGGTTTAGTTTTAGGAAGATAAATAAATATATCAAAGTATTTCATAAAGTTGTATCAATGTTCCTTCTAACATTAG 4481 AAGACTTACTGACTGAGGCCATCTGTGAACGACTAGGTGATCTCAGAATCCTTCCAGCTCTAATACCCTCTGACTAACAC 4561 TCACCCAGAATTGCTGTCTGTGCTGGCTGTGATCTGCCTCCAGGAGCATACGCCATCCTGCGTGCTGTGTCCATCACAGT 4641 GTCTGTGCTCGGTGCCTTACCACTGTCCGTGTCCTTGGACGCTGACTGGACAGAGAGGAGCCTGTCTCTCAGGGCACATG 4721 AGTCGTCGTGGCAGGAGGAGACGGGCCTCAGTCACAGTGTCACAGACCCTTGTCACAGTGGACACTAGTCATTCCTGCCA 4801 TGTCCTTGCAGCCCAGGAGGACTAAAAAGATTTTAATGAAGTCTGTGTTACTCATTCTGAAGAAAAGAACTTACCTGAGA 4881 GGAGTAATATTTTTTTAATATATATTGGGTCAGGGACAGGGATGGAGTGGTTGTTTTATGTTTACATTTTTAATAAGTAA 4961 AATAGAAGATTTAAGAACTAATATTTATGGTATTGAACTTTAAGTGTGATATATTCCTTAGAAAAACACAACTTTAATAA 5041 AAATGGAAACTAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Disease | 89782.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1065670. RNA binding protein: AGO2. Condition:4-thiouridine
... - Memczak S; Jens M; Elefsinioti A; Torti F; et al., 2013, Nature. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Memczak S; Jens M; Elefsinioti A; Torti F; et al. - Nature, 2013
Circular RNAs (circRNAs) in animals are an enigmatic class of RNA with unknown function. To explore circRNAs systematically, we sequenced and computationally analysed human, mouse and nematode RNA. We detected thousands of well-expressed, stable circRNAs, often showing tissue/developmental-stage-specific expression. Sequence analysis indicated important regulatory functions for circRNAs. We found that a human circRNA, antisense to the cerebellar degeneration-related protein 1 transcript (CDR1as), is densely bound by microRNA (miRNA) effector complexes and harbours 63 conserved binding sites for the ancient miRNA miR-7. Further analyses indicated that CDR1as functions to bind miR-7 in neuronal tissues. Human CDR1as expression in zebrafish impaired midbrain development, similar to knocking down miR-7, suggesting that CDR1as is a miRNA antagonist with a miRNA-binding capacity ten times higher than any other known transcript. Together, our data provide evidence that circRNAs form a large class of post-transcriptional regulators. Numerous circRNAs form by head-to-tail splicing of exons, suggesting previously unrecognized regulatory potential of coding sequences.
LinkOut: [PMID: 23446348]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | Prostate Tissue | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRX1760597. RNA binding protein: AGO2. Condition:AGO-CLIP-LNCaP_C
... - Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al., 2016, Neoplasia (New York, N.Y.). |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al. - Neoplasia (New York, N.Y.), 2016
MicroRNA (miRNA) deregulation in prostate cancer (PCa) contributes to PCa initiation and metastatic progression. To comprehensively define the cancer-associated changes in miRNA targeting and function in commonly studied models of PCa, we performed photoactivatable ribonucleoside-enhanced cross-linking immunoprecipitation of the Argonaute protein in a panel of PCa cell lines modeling different stages of PCa progression. Using this comprehensive catalogue of miRNA targets, we analyzed miRNA targeting on known drivers of PCa and examined tissue-specific and stage-specific pathway targeting by miRNAs. We found that androgen receptor is the most frequently targeted PCa oncogene and that miR-148a targets the largest number of known PCa drivers. Globally, tissue-specific and stage-specific changes in miRNA targeting are driven by homeostatic response to active oncogenic pathways. Our findings indicate that, even in advanced PCa, the miRNA pool adapts to regulate continuing alterations in the cancer genome to balance oncogenic molecular changes. These findings are important because they are the first to globally characterize miRNA changes in PCa and demonstrate how the miRNA target spectrum responds to staged tumorigenesis.
LinkOut: [PMID: 27292025]
|
CLIP-seq Support 1 for dataset GSM1065670 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / 4-thiouridine, 3_ML_LG |
Location of target site | ENST00000330198.4 | 3UTR | CAUGCAGUUUUAAAUGGGAGGUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
152 hsa-miR-2116-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT052654 | PLA2G4F | phospholipase A2 group IVF | 1 | 1 | ||||||||
MIRT064886 | ZBTB18 | zinc finger and BTB domain containing 18 | 2 | 2 | ||||||||
MIRT130162 | TXNIP | thioredoxin interacting protein | 2 | 6 | ||||||||
MIRT222068 | PURB | purine rich element binding protein B | 2 | 4 | ||||||||
MIRT232512 | MBD6 | methyl-CpG binding domain protein 6 | 2 | 2 | ||||||||
MIRT243458 | LMLN | leishmanolysin like peptidase | 2 | 2 | ||||||||
MIRT461322 | MRPS27 | mitochondrial ribosomal protein S27 | 2 | 2 | ||||||||
MIRT493800 | GAN | gigaxonin | 2 | 6 | ||||||||
MIRT495019 | C2CD4B | C2 calcium dependent domain containing 4B | 2 | 2 | ||||||||
MIRT497481 | XPR1 | xenotropic and polytropic retrovirus receptor 1 | 2 | 2 | ||||||||
MIRT497542 | PPTC7 | PTC7 protein phosphatase homolog | 2 | 2 | ||||||||
MIRT504017 | ACSL6 | acyl-CoA synthetase long chain family member 6 | 2 | 2 | ||||||||
MIRT504762 | TEP1 | telomerase associated protein 1 | 2 | 4 | ||||||||
MIRT504833 | EREG | epiregulin | 2 | 2 | ||||||||
MIRT505554 | SMUG1 | single-strand-selective monofunctional uracil-DNA glycosylase 1 | 2 | 2 | ||||||||
MIRT506088 | PPM1A | protein phosphatase, Mg2+/Mn2+ dependent 1A | 2 | 2 | ||||||||
MIRT513389 | TUBB4A | tubulin beta 4A class IVa | 2 | 2 | ||||||||
MIRT521643 | PROSC | pyridoxal phosphate binding protein | 2 | 2 | ||||||||
MIRT525286 | C18orf32 | chromosome 18 open reading frame 32 | 2 | 2 | ||||||||
MIRT525334 | CNGB1 | cyclic nucleotide gated channel beta 1 | 2 | 2 | ||||||||
MIRT525789 | SOD2 | superoxide dismutase 2 | 2 | 2 | ||||||||
MIRT526169 | ANKRD65 | ankyrin repeat domain 65 | 2 | 2 | ||||||||
MIRT526759 | GATS | GATS, stromal antigen 3 opposite strand | 2 | 2 | ||||||||
MIRT527223 | C3orf36 | chromosome 3 open reading frame 36 | 2 | 4 | ||||||||
MIRT527423 | NRL | neural retina leucine zipper | 2 | 2 | ||||||||
MIRT528795 | RAB32 | RAB32, member RAS oncogene family | 2 | 2 | ||||||||
MIRT529002 | SIGLEC14 | sialic acid binding Ig like lectin 14 | 2 | 4 | ||||||||
MIRT529792 | AP4S1 | adaptor related protein complex 4 sigma 1 subunit | 2 | 2 | ||||||||
MIRT530236 | PLXDC1 | plexin domain containing 1 | 2 | 2 | ||||||||
MIRT530511 | C4orf32 | family with sequence similarity 241 member A | 2 | 2 | ||||||||
MIRT530805 | GPR182 | G protein-coupled receptor 182 | 2 | 2 | ||||||||
MIRT531301 | GPR26 | G protein-coupled receptor 26 | 2 | 2 | ||||||||
MIRT534309 | SKIDA1 | SKI/DACH domain containing 1 | 2 | 2 | ||||||||
MIRT535303 | PHF12 | PHD finger protein 12 | 2 | 2 | ||||||||
MIRT544454 | KRBOX4 | KRAB box domain containing 4 | 2 | 2 | ||||||||
MIRT547160 | PDZD8 | PDZ domain containing 8 | 2 | 2 | ||||||||
MIRT548160 | FRAT2 | FRAT2, WNT signaling pathway regulator | 2 | 2 | ||||||||
MIRT551675 | BBS5 | Bardet-Biedl syndrome 5 | 2 | 2 | ||||||||
MIRT551692 | ASB16 | ankyrin repeat and SOCS box containing 16 | 2 | 2 | ||||||||
MIRT555855 | PAPD4 | poly(A) RNA polymerase D4, non-canonical | 2 | 2 | ||||||||
MIRT566196 | PTP4A1 | protein tyrosine phosphatase type IVA, member 1 | 2 | 2 | ||||||||
MIRT569417 | TRAF3IP2 | TRAF3 interacting protein 2 | 2 | 2 | ||||||||
MIRT570779 | ZNF468 | zinc finger protein 468 | 2 | 2 | ||||||||
MIRT572902 | RUNDC3B | RUN domain containing 3B | 2 | 2 | ||||||||
MIRT607664 | BTN3A2 | butyrophilin subfamily 3 member A2 | 2 | 2 | ||||||||
MIRT608835 | PTCHD1 | patched domain containing 1 | 2 | 2 | ||||||||
MIRT610299 | KLHL21 | kelch like family member 21 | 2 | 2 | ||||||||
MIRT610318 | CBY3 | chibby family member 3 | 2 | 2 | ||||||||
MIRT615460 | REPS1 | RALBP1 associated Eps domain containing 1 | 2 | 2 | ||||||||
MIRT618287 | ZNF682 | zinc finger protein 682 | 2 | 2 | ||||||||
MIRT619077 | DNAAF3 | dynein axonemal assembly factor 3 | 2 | 2 | ||||||||
MIRT620181 | TRIM72 | tripartite motif containing 72 | 2 | 2 | ||||||||
MIRT621543 | ZNF500 | zinc finger protein 500 | 2 | 2 | ||||||||
MIRT621619 | UHRF1BP1L | UHRF1 binding protein 1 like | 2 | 2 | ||||||||
MIRT621719 | TRAPPC10 | trafficking protein particle complex 10 | 2 | 2 | ||||||||
MIRT622715 | PLEKHA2 | pleckstrin homology domain containing A2 | 2 | 2 | ||||||||
MIRT625679 | SYAP1 | synapse associated protein 1 | 2 | 2 | ||||||||
MIRT626059 | AP3M1 | adaptor related protein complex 3 mu 1 subunit | 2 | 2 | ||||||||
MIRT626152 | NFYA | nuclear transcription factor Y subunit alpha | 2 | 2 | ||||||||
MIRT626172 | DNAJB13 | DnaJ heat shock protein family (Hsp40) member B13 | 2 | 2 | ||||||||
MIRT629678 | MYO1F | myosin IF | 2 | 2 | ||||||||
MIRT629821 | REL | REL proto-oncogene, NF-kB subunit | 2 | 2 | ||||||||
MIRT630641 | ELK1 | ELK1, ETS transcription factor | 2 | 2 | ||||||||
MIRT631231 | C7orf65 | chromosome 7 open reading frame 65 | 2 | 2 | ||||||||
MIRT633344 | GRK4 | G protein-coupled receptor kinase 4 | 2 | 2 | ||||||||
MIRT633552 | ATAD3C | ATPase family, AAA domain containing 3C | 2 | 2 | ||||||||
MIRT633595 | CFHR5 | complement factor H related 5 | 2 | 2 | ||||||||
MIRT635442 | SLC25A44 | solute carrier family 25 member 44 | 2 | 2 | ||||||||
MIRT636490 | GRIN2B | glutamate ionotropic receptor NMDA type subunit 2B | 2 | 2 | ||||||||
MIRT636867 | ARSE | arylsulfatase E (chondrodysplasia punctata 1) | 2 | 2 | ||||||||
MIRT637180 | TMEM50A | transmembrane protein 50A | 2 | 2 | ||||||||
MIRT638726 | FOXK1 | forkhead box K1 | 2 | 2 | ||||||||
MIRT638921 | CALCOCO2 | calcium binding and coiled-coil domain 2 | 2 | 2 | ||||||||
MIRT639830 | ZKSCAN1 | zinc finger with KRAB and SCAN domains 1 | 2 | 2 | ||||||||
MIRT641013 | ANKFY1 | ankyrin repeat and FYVE domain containing 1 | 2 | 2 | ||||||||
MIRT641817 | ULK2 | unc-51 like autophagy activating kinase 2 | 2 | 2 | ||||||||
MIRT641966 | PWWP2A | PWWP domain containing 2A | 2 | 2 | ||||||||
MIRT643596 | SPAG16 | sperm associated antigen 16 | 2 | 2 | ||||||||
MIRT643684 | AMER3 | APC membrane recruitment protein 3 | 2 | 2 | ||||||||
MIRT644453 | ALDOC | aldolase, fructose-bisphosphate C | 2 | 2 | ||||||||
MIRT645278 | SLC38A5 | solute carrier family 38 member 5 | 2 | 2 | ||||||||
MIRT646676 | CCDC69 | coiled-coil domain containing 69 | 2 | 2 | ||||||||
MIRT646833 | TLDC1 | TBC/LysM-associated domain containing 1 | 2 | 2 | ||||||||
MIRT648206 | TRIM35 | tripartite motif containing 35 | 2 | 2 | ||||||||
MIRT648265 | ZNF582 | zinc finger protein 582 | 2 | 2 | ||||||||
MIRT648858 | PDLIM3 | PDZ and LIM domain 3 | 2 | 2 | ||||||||
MIRT648891 | TUBGCP5 | tubulin gamma complex associated protein 5 | 2 | 2 | ||||||||
MIRT649726 | LTBP2 | latent transforming growth factor beta binding protein 2 | 2 | 2 | ||||||||
MIRT649819 | PSMC1 | proteasome 26S subunit, ATPase 1 | 2 | 2 | ||||||||
MIRT652357 | TMEM92 | transmembrane protein 92 | 2 | 2 | ||||||||
MIRT652915 | SYNJ2BP | synaptojanin 2 binding protein | 2 | 2 | ||||||||
MIRT654054 | S1PR1 | sphingosine-1-phosphate receptor 1 | 2 | 2 | ||||||||
MIRT654130 | RPL14 | ribosomal protein L14 | 2 | 2 | ||||||||
MIRT654374 | RBM23 | RNA binding motif protein 23 | 2 | 2 | ||||||||
MIRT654503 | RABIF | RAB interacting factor | 2 | 2 | ||||||||
MIRT655743 | NR2F2 | nuclear receptor subfamily 2 group F member 2 | 2 | 2 | ||||||||
MIRT656543 | MACC1 | MACC1, MET transcriptional regulator | 2 | 2 | ||||||||
MIRT656863 | KIN | Kin17 DNA and RNA binding protein | 2 | 2 | ||||||||
MIRT657233 | IER5 | immediate early response 5 | 2 | 2 | ||||||||
MIRT657464 | C21orf33 | chromosome 21 open reading frame 33 | 2 | 2 | ||||||||
MIRT658243 | FAXC | failed axon connections homolog | 2 | 2 | ||||||||
MIRT658456 | FAM13B | family with sequence similarity 13 member B | 2 | 2 | ||||||||
MIRT658510 | ETV3 | ETS variant 3 | 2 | 2 | ||||||||
MIRT658574 | EPHB2 | EPH receptor B2 | 2 | 2 | ||||||||
MIRT659000 | DIAPH1 | diaphanous related formin 1 | 2 | 2 | ||||||||
MIRT659642 | CDK2 | cyclin dependent kinase 2 | 2 | 2 | ||||||||
MIRT660330 | BCL11B | B-cell CLL/lymphoma 11B | 2 | 2 | ||||||||
MIRT660803 | AIFM2 | apoptosis inducing factor, mitochondria associated 2 | 2 | 2 | ||||||||
MIRT660990 | ABHD2 | abhydrolase domain containing 2 | 2 | 2 | ||||||||
MIRT662980 | PAK3 | p21 (RAC1) activated kinase 3 | 2 | 2 | ||||||||
MIRT663208 | DARS2 | aspartyl-tRNA synthetase 2, mitochondrial | 2 | 2 | ||||||||
MIRT664535 | EXOG | exo/endonuclease G | 2 | 2 | ||||||||
MIRT666119 | SRRM4 | serine/arginine repetitive matrix 4 | 2 | 2 | ||||||||
MIRT668146 | GDPD1 | glycerophosphodiester phosphodiesterase domain containing 1 | 2 | 2 | ||||||||
MIRT668831 | CYCS | cytochrome c, somatic | 2 | 2 | ||||||||
MIRT673401 | WNT7B | Wnt family member 7B | 2 | 2 | ||||||||
MIRT676356 | ZNF844 | zinc finger protein 844 | 2 | 2 | ||||||||
MIRT676442 | PLEKHM3 | pleckstrin homology domain containing M3 | 2 | 2 | ||||||||
MIRT683417 | ZNF878 | zinc finger protein 878 | 2 | 2 | ||||||||
MIRT686353 | USP15 | ubiquitin specific peptidase 15 | 2 | 2 | ||||||||
MIRT690686 | PTCHD3 | patched domain containing 3 | 2 | 2 | ||||||||
MIRT696043 | KCNK6 | potassium two pore domain channel subfamily K member 6 | 2 | 2 | ||||||||
MIRT700854 | PERP | PERP, TP53 apoptosis effector | 2 | 2 | ||||||||
MIRT709639 | C2orf91 | chromosome 2 open reading frame 91 | 2 | 2 | ||||||||
MIRT709956 | TRUB2 | TruB pseudouridine synthase family member 2 | 2 | 2 | ||||||||
MIRT711652 | RAB21 | RAB21, member RAS oncogene family | 2 | 2 | ||||||||
MIRT711847 | AMOTL2 | angiomotin like 2 | 2 | 2 | ||||||||
MIRT713388 | NLN | neurolysin | 2 | 2 | ||||||||
MIRT713933 | PIGR | polymeric immunoglobulin receptor | 2 | 2 | ||||||||
MIRT714991 | TSPAN11 | tetraspanin 11 | 2 | 2 | ||||||||
MIRT715728 | PIAS2 | protein inhibitor of activated STAT 2 | 2 | 2 | ||||||||
MIRT716050 | GRAMD1B | GRAM domain containing 1B | 2 | 2 | ||||||||
MIRT717141 | DLEU1 | deleted in lymphocytic leukemia 1 (non-protein coding) | 2 | 2 | ||||||||
MIRT717412 | ZCCHC24 | zinc finger CCHC-type containing 24 | 2 | 2 | ||||||||
MIRT717525 | GATAD2B | GATA zinc finger domain containing 2B | 2 | 2 | ||||||||
MIRT717914 | LRRC15 | leucine rich repeat containing 15 | 2 | 2 | ||||||||
MIRT717969 | PXMP4 | peroxisomal membrane protein 4 | 2 | 2 | ||||||||
MIRT718742 | ATP9A | ATPase phospholipid transporting 9A (putative) | 2 | 2 | ||||||||
MIRT719096 | PCYT1A | phosphate cytidylyltransferase 1, choline, alpha | 2 | 2 | ||||||||
MIRT719142 | DPYSL5 | dihydropyrimidinase like 5 | 2 | 2 | ||||||||
MIRT719221 | CAMK4 | calcium/calmodulin dependent protein kinase IV | 2 | 2 | ||||||||
MIRT719524 | SRCIN1 | SRC kinase signaling inhibitor 1 | 2 | 2 | ||||||||
MIRT719921 | PRKAB1 | protein kinase AMP-activated non-catalytic subunit beta 1 | 2 | 2 | ||||||||
MIRT720324 | CAMK2G | calcium/calmodulin dependent protein kinase II gamma | 2 | 2 | ||||||||
MIRT720719 | RAPGEF6 | Rap guanine nucleotide exchange factor 6 | 2 | 2 | ||||||||
MIRT721636 | MYLK3 | myosin light chain kinase 3 | 2 | 2 | ||||||||
MIRT722611 | TEAD1 | TEA domain transcription factor 1 | 2 | 2 | ||||||||
MIRT724381 | NEK8 | NIMA related kinase 8 | 2 | 2 | ||||||||
MIRT724526 | ATP2B1 | ATPase plasma membrane Ca2+ transporting 1 | 2 | 2 | ||||||||
MIRT725454 | HIPK3 | homeodomain interacting protein kinase 3 | 2 | 2 | ||||||||
MIRT725549 | DNMT3A | DNA methyltransferase 3 alpha | 2 | 2 | ||||||||
MIRT725637 | BTBD9 | BTB domain containing 9 | 2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|